The Biggest Stories Shaping Reproductive Medicine in 2026
As provided by Janene Oleaga, Esq. family formation attorney and reproductive rights advocate.
The fertility industry is experiencing one of its most transformative periods in decades. Scientific advances, shifting legal landscapes, insurance coverage expansion, artificial intelligence, and cross-border third party family building are reshaping reproductive medicine at a rapid pace. Here are the stories dominating conversations among physicians, embryologists, lawyers, insurance providers, and policymakers.
1. IVF Insurance Coverage Continues to Expand Across the United States ⭐⭐⭐⭐⭐
Perhaps the biggest legal story of 2026 is the continued expansion of fertility insurance mandates across the United States. Several states are proposing bills or implementing laws with broader IVF coverage, while employers continue to evaluate fertility benefits as part of competitive compensation packages. The debate has shifted from whether fertility care should be covered to who qualifies and how much coverage should be provided.
We’re witnessing fertility treatment become recognized as essential healthcare rather than an elective benefit. The next frontier isn’t simply expanding coverage—it’s ensuring that LGBTQ+ families, single intended parents, cancer survivors, and people having children with the assistance of donors or gestational surrogates receive equal access to those benefits.
As of 2026 there are 15 states plus the District of Columbia that require health insurance plans to cover IVF, and a handful of states that require some form of infertility coverage. The scope of coverage among these states varies greatly with Massachusetts, Illinois, New Jersey, New York, California, Maryland, Connecticut, Rhode Island, and Maine providing the strongest coverage in the United States.
2. Artificial Intelligence is Entering the IVF Lab ⭐⭐⭐⭐⭐
Artificial Intelligence Is Transforming IVF But Human Judgment Remains Essential
Artificial intelligence (AI) is rapidly transforming assisted reproductive technology (ART), with applications now extending beyond research settings into IVF laboratories worldwide. AI-powered algorithms are being used to assist with embryo assessment, predict implantation potential, personalize ovarian stimulation protocols, and improve laboratory efficiency. Traditionally, embryo grading has relied on subjective evaluation by embryologists, but machine learning models can analyze thousands of embryo images to identify developmental patterns that may not be visible to the human eye. While early studies suggest AI may achieve a respectable level of accuracy in predicting outcomes such as blastocyst development and implantation potential, experts emphasize that AI should complement—not replace—clinical expertise. AI is also being explored to personalize ovarian stimulation by integrating patient-specific data, including age, AMH levels, ovarian reserve, and prior IVF response, to optimize treatment strategies and reduce complications such as ovarian hyperstimulation syndrome. Additional applications include automated embryo monitoring, predicting fertilization success, improving laboratory quality control, and standardizing practices across IVF centers. As these technologies continue to evolve, prospective validation and careful clinical oversight will be essential to ensure AI enhances reproductive care while maintaining patient-centered decision-making.
Limitations and Ethical Considerations
Despite remarkable advances, AI in reproductive medicine raises important ethical, legal, and regulatory questions. AI systems trained primarily on data from certain populations or fertility centers may perform less accurately when applied to more diverse patient populations. Questions also remain regarding regulatory oversight, patient privacy, cybersecurity, and the ownership and secondary use of reproductive data used to train AI algorithms.
The Legal Perspective
Artificial intelligence has tremendous potential to improve consistency and support clinical decision-making in IVF laboratories, but technology cannot replace informed medical judgment or thoughtful legal counseling. Patients deserve transparency about how AI is being used, whether it influences embryo selection or treatment recommendations, and what safeguards exist to ensure that these tools are accurate, unbiased, and appropriately supervised. As AI becomes more integrated into reproductive medicine, informed consent, data privacy, and professional accountability will become increasingly important legal considerations.
As AI continues to evolve, fertility law will need to develop in tandem with technological advances. Attorneys representing intended parents, gamete donors, gestational carriers, fertility clinics, and physicians should anticipate new questions involving informed consent, disclosure obligations, professional standards of care, and liability when AI-assisted clinical decisions influence reproductive outcome.
3. Cross-Border Surrogacy is Growing Despite Legal Uncertainty ⭐⭐⭐⭐⭐
Although surrogacy programs may be available in other parts of the world at a lower initial cost, international intended parents are increasingly choosing the United States because of its well-developed legal framework, experienced fertility professionals, and predictable parentage procedures. States with comprehensive assisted reproduction laws allow intended parents to establish legal parentage before or shortly after birth, reducing uncertainty during one of the most important moments of the family-building journey. When combined with accredited IVF clinics, established surrogacy agencies, and coordinated legal representation, these protections help minimize the risk of disputes involving parental rights, citizenship documentation, or newborn travel.
At the same time, several countries continue to tighten restrictions on commercial surrogacy or prohibit international intended parents from participating altogether. These legal changes have shifted the focus from finding the least expensive destination to identifying jurisdictions that offer stability, enforceable agreements, and clear judicial procedures. As a result, legal due diligence has become just as important as selecting a fertility clinic or matching with a gestational carrier.
Intended parents increasingly understand that the least expensive program isn’t necessarily the safest. Legal certainty surrounding parentage, citizenship, and newborn travel often determines whether a journey is successful.
4. Parentage Law Has Become Just as Important as IVF Success Rates ⭐⭐⭐⭐☆
As some states move towards modernize parentage statutes and protecting third-party family building, other states are attacking gestational surrogacy, LGBTQ+ parents, and access to reproductive care. As a result, lawyers and fertility clinics are emphasizing legal planning at the outset of any third-part reproductive journey and absolutely before embryos are created or transferred to a gestational surrogate. Intended parents are asking questions about the availability of pre-birth orders, and specific legalities surrounding donor agreements, embryo ownership, and interstate recognition of legal parentage.
Biology alone does not determine legal parentage. In assisted reproduction, legal parentage is determined based on intent and consent at the outset of any reproductive arrangement.
5. Fertility Preservation is Becoming Mainstream ⭐⭐⭐⭐☆
Fertility preservation has moved from a specialized option primarily used by patients facing medical challenges to a mainstream component of reproductive planning. Egg freezing, sperm banking, embryo cryopreservation, and fertility preservation before cancer treatment are becoming increasingly common as individuals seek greater control over their future family-building options. Advances in vitrification technology have improved the survival rates of frozen eggs and embryos, making cryopreservation a more reliable and widely accepted practice. At the same time, more employers are offering fertility preservation benefits as part of broader family-building and reproductive health packages, recognizing that employees may delay parenthood for personal, medical, educational, or professional reasons. Younger generations are increasingly viewing fertility preservation as part of long-term financial and life planning, similar to retirement savings or other investments in future security, and even including embryo disposition clauses in prenuptial agreements.
Patients are thinking years ahead. We’re seeing more individuals preserve fertility before marriage, before cancer treatment, and before significant life changes. The law is only beginning to catch up with these evolving family structures.
As fertility preservation becomes more common, legal questions surrounding ownership, storage, disposition, inheritance, and future use of genetic material are becoming increasingly important. Clear agreements addressing ownership and dispositional control of frozen eggs, sperm, and embryos can help prevent disputes if relationships change, medical circumstances evolve, or a patient dies before using preserved genetic material. As reproductive technology continues to expand the possibilities for family building, legal planning will play an increasingly important role in protecting patients’ reproductive choices and intentions.
6. Embryo Disposition Disputes Continue to Increase ⭐⭐⭐⭐☆
As the number of embryos remaining in long-term cryogenic storage continues to grow, disputes regarding ownership and dispositional control of embryos are reaching courts across the country with increasing frequency. These disputes often arise during divorce or separation, upon the death of a party, or when prompted by a change in one party’s reproductive wishes, creating complex questions at the intersection of family law, contract law, and reproductive autonomy. Courts have taken different approaches to resolving embryo disputes, with some focusing on prior agreements between the parties, while others weighing competing interests, including the desire to avoid unwanted parenthood or preserve the potential for genetic parenthood. Fertility clinics are responding by updating consent forms and encouraging patients to make clear decisions about future embryo disposition before treatment begins.
In some states, embryos are a unique form of property. Couples should never assume they’ll agree years later about disposition of cryopreserved embryos created during a relationship. Comprehensive agreements signed before IVF, or while the parties intentions are aligned, remain the best way to reduce future conflict.
Because reproductive decisions can become deeply personal and emotionally complex over time, proactive legal planning is essential. A carefully drafted embryo disposition agreement can address potential outcomes such as continued storage, donation to another person or for scientific research, destruction, or use by one party after separation or death, depending on applicable law. As assisted reproductive technology continues to expand, clear documentation of the parties’ intentions at the time embryos are created remains one of the most effective tools for preventing future disputes and protecting reproductive autonomy.
7. Genetics and Personalized Medicine Continue to Advance ⭐⭐⭐⭐☆
Advances in genetics and personalized medicine are transforming the way fertility specialists evaluate patients, assess reproductive risks, and develop individualized treatment plans. Expanded gestational carrier screening allows prospective parents to identify a broader range of inherited conditions that could affect future children, while improvements in preimplantation genetic testing (PGT) provide additional information about embryos before transfer. Researchers are also exploring more sophisticated approaches to personalize IVF treatment, including the use of genetic, hormonal, and clinical data to improve embryo selection, optimize implantation rates, and reduce unnecessary interventions. As genetic technologies become more accessible, patients are increasingly seeking guidance about what information these tests can provide and how results may influence their reproductive decisions.
As genetic testing becomes more sophisticated, informed consent becomes more important. Patients need to understand not only what testing can reveal, but also its limitations.
While genetic testing can provide valuable insights, it does not guarantee a healthy pregnancy or predict every potential medical outcome. Fertility professionals and attorneys must continue to emphasize the importance of accurate counseling, privacy protections, and thoughtful decision-making as reproductive genetics continues to evolve. As personalized medicine advances, the future of fertility care will increasingly focus on tailoring treatment to each patient’s unique medical history, reproductive goals, and values.
8. Global Fertility Networks Are Replacing Single-Country Care ⭐⭐⭐⭐☆
Modern fertility care is increasingly becoming a global process, with patients accessing medical treatment, genetic testing, cryostorage, legal services, gamete donation, and gestational surrogacy across multiple jurisdictions. Advances in reproductive technology, combined with increased mobility and laws permitting cross-border family building, have created complex fertility journeys that often involve several countries, states, and regulatory systems. Fertility clinics, fertility law firms, surrogacy agencies, genetic testing companies, and specialized providers are increasingly developing international partnerships to help coordinate these multi-jurisdictional arrangements.
Today’s family building journey often spans multiple jurisdictions. A single case may involve intended parents in Europe, an egg donor in another country, embryos stored in one state, and a gestational surrogate in another state. Coordinating those legal systems has become one of the most important aspects of modern family building.
As international fertility arrangements become more common, careful legal planning is essential to address issues such as parentage recognition, donor agreements, embryo ownership, FDA and international transportation requirements, citizenship concerns, and compliance with varying and shifting reproductive laws. Differences among countries regarding compensation, donor anonymity, surrogacy eligibility, and recognition of parental rights can create significant challenges for intended parents and professionals coordinating care. The future of third party assisted reproduction will require greater collaboration among international providers and a multidisciplinary approach that integrates medical, legal, logistical, and ethical considerations. For many patients, successful family building now depends not only on reproductive medicine but also on navigating a complex global network of laws and professionals.
9. International Regulation is Becoming More Active ⭐⭐⭐⭐☆
Countries around the world are increasingly reevaluating their laws governing assisted reproductive technology, including gestational surrogacy, embryo research, donor anonymity, and access to reproductive services. Jurisdictions such as the United Kingdom continue to consider reforms to modernize surrogacy frameworks, while other countries are revisiting restrictions and ethical guidelines surrounding emerging reproductive technologies. These legal developments can significantly influence where intended parents choose to pursue fertility treatment, particularly as they evaluate issues such as parentage recognition, donor access, citizenship, and the enforceability of agreements.
Every legal reform has the potential to impact international family building. Intended parents should avoid assuming that a jurisdiction’s laws will remain stable throughout a surrogacy journey that may last two years or more.
Because fertility journeys often extend over many months or even years, changes in law, policy, or court interpretation during treatment can create unexpected challenges for intended parents. Careful legal due diligence before entering an international arrangement is essential to understand current requirements, anticipate potential changes, and develop contingency plans. As third-party ART arrangements continue to cross borders, international fertility planning will increasingly require coordination among medical providers, attorneys, and regulatory experts familiar with the evolving legal landscape.
10. Access to Fertility Care Remains the Central Policy Debate ⭐⭐⭐⭐⭐
Despite extraordinary advances in reproductive medicine, access to fertility care remains one of the most significant challenges facing patients today. The high out-of-pocket expense of IVF, fertility medications, genetic testing, donor conception, and surrogacy continues to place treatment out of reach for many individuals and families who need these services in order to have a child. Policymakers, employers, physicians, and patient advocates are increasingly focused on expanding insurance coverage, improving affordability, and ensuring that access to fertility care reflects the diversity of modern families, including single parents and LGBTQ+ individuals. At the same time, discussions around expanding access must also address ethical oversight, patient protections, equitable treatment, and the responsible use of rapidly advancing reproductive technologies.
The conversation has evolved beyond simply creating families. Today’s discussions are focused on equitable access to care and protecting families through thoughtful legislation, ethical medical practices, and legal frameworks that recognize the many different ways people become parents.
As reproductive technologies continue to redefine what is possible, the future of fertility care will depend not only on scientific innovation but also on policies that ensure those innovations are accessible, safe, and legally protected.
Why This Matters
Collectively, these trends demonstrate that reproductive medicine is entering a new era—one where science, law, technology, and public policy are becoming inseparable. The next decade of reproductive medicine will require collaboration across disciplines bringing together physicians, scientists, attorneys, legislators, ethicists, insurers, patient advocates, and policymakers to create systems that keep pace with advances in medical technology while prioritizing bodily autonomy, equitable access to care, informed consent, privacy rights, and legal protections.
